STATKING President to Participate in Panel Discussion at Texas Medical Device Alliance Meeting

CINCINNATI--()--Dennis W. King, PhD, PStat, President and CEO of STATKING Clinical Services (SCS), in Cincinnati, OH will participate in a panel discussion of Clinical Research and CRO Experiences and Expectations. The panel will consist of pharmaceutical and medical device executives. The panel discussion will be conducted at the October meeting of the Texas Medical Device Alliance on October 17, 2019 from 2-4 pm at the Norris Conference Center in Austin, TX. “I am very pleased to participate in what I am sure will be a lively and informative discussion of clinical research topics with this excellent panel of discussants,” commented Dennis W. King, President and CEO of STATKING Clinical Services.

About Texas Medical Device Alliance

The Texas Medical Device Alliance (TMDA), formerly known as the Medical Device Action Group, was founded in February 2009. At that time, 35 individuals from the medical device community in Texas came together to discuss how to build a viable medical device industry that could rival other similar industries around the nation. Effective April 2011, TMDA became a non-profit corporation, organized under the Texas Business Organizations Code. The mission of TMDA is to help medical device companies become and remain successful in Texas.

Participants in TMDA meet quarterly to support networking among participants and host feature presentations that address critical issues such as certification, regulatory compliance, clinical trials, reimbursement, and other informative topics. Participants include members of the medical community, biotech industry, academia, the investment and legal communities, and municipal organizations.

TMDA is a volunteer, sponsorship-based industry organization. There are no membership fees, events are open to all and there are typically no fees to attend an event. For more information, visit https://texmda.org/.

About STATKING Clinical Services

STATKING Clinical Services provides clinical trial services (clinical trial management, protocol development, biostatistics, clinical data management, clinical study monitoring, medical writing, medical monitoring, safety reporting, and project management) for clinical trials for the regulatory approval of novel drug and medical device products. The company is headquartered in Fairfield, OH. The company has provided support on 12 NDAs, 13 PMAs, 2 BLAs, 3 NADAs and numerous 510Ks over the past 30 years of service to the pharmaceutical, medical device and animal health industries. For more information, visit www.statkingclinical.com.

Contacts

STATKING Clinical Services
Rod Lashley, Executive Vice President 513-858-2989 x303
rod@statkingclinical.com

Release Summary

Dennis W. King, PhD, President and CEO of STATKING Clinical Services will participate in a panel discussion at the TMDA Meeting in Austin, TX.

Contacts

STATKING Clinical Services
Rod Lashley, Executive Vice President 513-858-2989 x303
rod@statkingclinical.com